VWA5A Polyclonal Antibody
RD75625A
ApplicationsELISA, ImmunoHistoChemistry
Product group Antibodies
ReactivityHuman
TargetVWA5A
Overview
- SupplierReddot Biotech
- Product NameVWA5A Polyclonal Antibody
- Delivery Days Customer5
- ApplicationsELISA, ImmunoHistoChemistry
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration0.9 mg/ml
- ConjugateUnconjugated
- Gene ID4013
- Target nameVWA5A
- Target descriptionvon Willebrand factor A domain containing 5A
- Target synonymsBCSC-1, BCSC1, LOH11CR2A, von Willebrand factor A domain-containing protein 5A, breast cancer suppressor candidate 1, loss of heterozygosity 11 chromosomal region 2 gene A protein, loss of heterozygosity, 11, chromosomal region 2, gene A, ortholog of mouse AW551984
- HostRabbit
- IsotypeIgG
- Protein IDO00534
- Protein Namevon Willebrand factor A domain-containing protein 5A
- Scientific DescriptionThis is a VWA5A Polyclonal Antibody from Reddot Biotech. This product is for Research Use Only. - VWA5A (von Willebrand factor A domain containing 5A), also known as BCSC-1 (breast cancer suppressor candidate 1) or LOH11CR2A (loss of heterozygosity 11 chromosomal region 2 gene A protein), is a 786 amino acid protein containing one VIT domain and one VWFA domain. VWA5A is expressed at low levels in various tissues, with no expression found in 80% of tumor cell lines. Likely acting as a tumor suppressor gene, deletion of VWA5A leads to loss of heterozygosity (LOH) in breast and ovarian tumors, and may have an important role as a potential gene therapy target. Abnormal expression of VWA5A may lead to an increase in adhesion of CNE-2L2 cells associated with an increase in expression of E-cadherin, alpha-catenin, and p53, resulting in a decrease of malignant activity in cells with ectopic expression of VWA5A.
- ReactivityHuman
- Storage Instruction-20°C
- UNSPSC41116161






